Fighting the pandemic will remain a top priority in 2021, not least for the Biopharma companies working on the next…
Browsing: Biotech
According to a new report from the Centers of Disease Control and Prevention, a fast-moving strain of the coronavirus has…
Johnson & Johnson’s DePuy Synthes division has received FDA clearance for its robotic-assisted orthopedic surgical platform for total knee replacements.The…
Shortly after Abbott completed its delivery of 150 million rapid antigen tests to the federal government for widespread distribution against…
Haemonetics has moved to acquire Cardiva Medical, maker of bloodstopping and vascular closure systems used during hospital procedures, in a…
Philips has moved to acquire Capsule Technologies—a provider of data platforms that aim to connect all of the medical devices…
Researchers at the University of Cambridge have developed a DNA test to help spot dangerous secondary infections that may develop…
If racial justice wasn’t front of mind for biopharma, the events of 2020, from the COVID-19 pandemic to police brutality,…
Earlier this week at the J.P. Morgan Healthcare Conference, Thermo Fisher Scientific CEO Marc Casper said 2021 is going to…
Xontogeny’s Landos Biopharma is jumping into warm biotech IPO waters as it looks to go public with a $100 million…